Prehospital partial REBOA for exsanguonating torso haemorrhage. The P-PRO study published today in @JAMASurgery. This is the environment, and these are the patients REBOA was developed for. https://t.co/juwFuGycJ1 Congrats @robbielendrum @LDNairamb and all involved.

OK that went well, I think 😎. Here are my reading of the sessions: SESSION 1: UK-REBOA Most would say REBOA as currently delivered does not have a place in ED phase of care of major trauma patients thought to have non-compressible haemorrhage. BUT: ? - Does it have a niche

@janjansenuk UK-REBOA found REBOA was assoc'd with delayed definitive haemorrhahe control. @nigeltai suggests this may be because it is disruptive technology - the temporary physiological stability may change decision making in ways that end up not being advantageous

Major Trauma Haemorrhage: What Now? @wellcometrust @Explorewellcome Session 1 REBOA Results from @ukreboatrial @janjansenuk Prehospital REBOA @robbielendrum Military REBOA @nigeltai The trial compared 2 treatment strategies But many questions remain! Brilliant panel discussion

150+ registrations in 6 hours! Join us for this national discussion on where we go with the management of critically bleeding trauma patients. Free registration, online or there will be a few in-person slots. (All MTCs and Air ambulances have reserved in-person places).

UK & Ireland Major Trauma Haemorrhage: What Now? What Next? 12th & 13th March, Wellcome Trust, London & online Register for free here: https://t.co/COstJgRhPk Critical bleeding is still the leading cause of potentially preventable deaths in major trauma patients. Despite huge

🚨 🔥🌶️ #REBOA On today's episode we welcome @karimbrohi to discuss the results of the seminal UK-REBOA RCT. Is this the end of balloons in trauma?? Or a bunch of hot air? Decide for yourself: https://t.co/63gpklNA8J 🎧 @clarkninam @georgoff

Super podcast featuring @janjansenuk discussing the design & results of the @UKREBOATrial - well worth a listen.

We made a thing. With a very patient Prof Jansen. @janjansenuk We discussed the UK REBOA Trial. 🎈 🎙️ 20 min podcast 🎙️ Would be great to get your thoughts 💭 Should we make more?

In trauma patients with exsanguinating hemorrhage, a strategy of balloon occlusion of the aorta (REBOA) and standard care in the emergency department does not reduce, and may increase, mortality compared with standard care alone.

JAMA Associate Editor Christopher W. Seymour, MD, MSc, summarizes the November 21, Blood, Bleeding, and Transfusion, theme issue.

#TBL 441: UK-REBOA - Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage https://t.co/uWIa5swJeN Article by @janjansenuk Review by @celiabradford #FOAMed #Trauma

Emergency department resuscitative endovascular balloon occlusion of the aorta in trauma patients with exsanguinating hemorrhage Read the results of the UK-REBOA trial published in @JAMA_current #ISRCTN: https://t.co/0TTHl9idpK https://t.co/r4UrD5Lf4O

The @UKREBOATrial is one of the top 5 most viewed articles in @JAMA_current this week! The trial showed that REBOA in the ED for exsanguinating haemorrhage did not reduce, and may increase, mortality. See

Absolute belter of an issue. Lots to unpack. - @CRYOSTAT_2 and @UKREBOATrial - Practice changing #STRATUS trial - #InPUT study on 🌎 ICU transfusion practice - @AABB guidelines on 🩸 transfusion across many settings @SimonStanworth @nicola_curry @DataDrivenBTRU @RDMOxford

This is an awesome trial Bayesian group sequential trial in a complex trauma setting, with a really important finding. Chapeau

Our UK-REBOA trial is out. A huge endeavour with major implications for UK trauma care-showing that use of #REBOA in the ED for exsanguinating haemorrhage did not reduce, and may increase mortality. Huge thanks to the entire trial team. @janjansenuk https://t.co/UKbqMFTmKr

@UKREBOATrial & @CRYOSTAT_2 results now available online... really well done to those who made these trials possible👇🏻

A massive day for UK trauma with the publication in @JAMA_current of two game-changing trauma trials: @CRYOSTAT_2 and @UKREBOATrial. Both turning points in how we understand and treat trauma patients. UK-REBOA: https://t.co/PLEs7LXZ5o CRYOSTAT-2: https://t.co/U9Yv0857JO

UK-REBOA Trial is now out in @JAMA_current https://t.co/YEkCdEX9hW The video of the presentation from #CCR23 is now out also https://t.co/0k58s74M9J @MarionKCampbell @janjansenuk @UKREBOATrial